Kenzie Maclsaac
Private Equity Investor bij Cure Ventures Management LP
Actieve functies van Kenzie Maclsaac
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01-03-2022 | - |
Loopbaan van Kenzie Maclsaac
Eerdere bekende functies van Kenzie Maclsaac
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Directeur/Bestuurslid | 01-12-2018 | 03-12-2022 |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 01-04-2018 | 30-11-2018 |
Opleiding van Kenzie Maclsaac
| Carleton University | Undergraduate Degree |
| University of Toronto | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Canada | 3 |
Operationeel
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Finance | 3 |
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
Fog Pharmaceuticals, Inc.
Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Kenzie Maclsaac
- Ervaring
